The Chinese Hamster Ovary Cell-Based H9 HA Subunit Avian Influenza Vaccine Provides Complete Protection against the H9N2 Virus Challenge in Chickens

Shunfan Zhu,Zhenyu Nie,Ying Che,Jianhong Shu,Sufang Wu,Yulong He,Youqiang Wu,Hong Qian,Huapeng Feng,Qiang Zhang

DOI: https://doi.org/10.3390/v16010163

2024-01-23

Viruses

Abstract:(1) Background: Avian influenza has attracted widespread attention because of its severe effect on the poultry industry and potential threat to human health. The H9N2 subtype of avian influenza viruses was the most prevalent in chickens, and there are several commercial vaccines available for the prevention of the H9N2 subtype of avian influenza viruses. However, due to the prompt antigenic drift and antigenic shift of influenza viruses, outbreaks of H9N2 viruses still continuously occur, so surveillance and vaccine updates for H9N2 subtype avian influenza viruses are particularly important. (2) Methods: In this study, we constructed a stable Chinese hamster ovary cell line (CHO) to express the H9 hemagglutinin (HA) protein of the major prevalent H9N2 strain A/chicken/Daye/DY0602/2017 with genetic engineering technology, and then a subunit H9 avian influenza vaccine was prepared using the purified HA protein with a water-in-oil adjuvant. (3) Results: The results showed that the HI antibodies significantly increased after vaccination with the H9 subunit vaccine in specific-pathogen-free (SPF) chickens with a dose–dependent potency of the immunized HA protein, and the 50 μg or more per dose HA protein could provide complete protection against the H9N2 virus challenge. (4) Conclusions: These results indicate that the CHO expression system could be a platform used to develop the subunit vaccine against H9 influenza viruses in chickens.

virology

What problem does this paper attempt to address?

The problem this paper attempts to address is the persistent spread of the H9N2 subtype avian influenza virus in chicken flocks. Although some commercial vaccines are available to prevent the H9N2 subtype avian influenza virus, outbreaks of the H9N2 virus still occur frequently due to the rapid antigenic drift and shift of the influenza virus. Therefore, monitoring and updating vaccines for the H9N2 subtype avian influenza virus is particularly important.

To tackle this challenge, researchers constructed a stable Chinese hamster ovary (CHO) cell line using genetic engineering techniques to express the hemagglutinin (HA) protein of the major epidemic H9N2 strain A/chicken/Daye/DY0602/2017. They prepared an H9 subunit avian influenza vaccine using the purified HA protein with a water-in-oil adjuvant. The study results showed that this vaccine could significantly increase the HI antibody levels in specific pathogen-free (SPF) chickens, and an HA protein dose of 50 µg or higher could completely protect chickens from H9N2 virus challenge. This indicates that the CHO expression system can serve as a platform for developing subunit vaccines against the H9 influenza virus.